NS5A inhibitor

^[1]

Introduction

↑ Orciari Herman A, Fairchild DG] New Once-Daily Hepatitis C Pill Effective Across 6 Genotypes. Physician's First Watch, Nov 16, 2015 David G. Fairchild, MD, MPH, Editor-in-Chief Massachusetts Medical Society http://www.jwatch.org
Foster GR, Afdhal N, Roberts SK et al Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection. N Eng J Med. November 17, 2015 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/26575258 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1512612
Ward JW, Mermin JH Simple, Effective, but Out of Reach? Public Health Implications of HCV Drugs. N Eng J Med. November 17, 2015 PMID: https://www.ncbi.nlm.nih.gov/pubmed/26575359